Ligand - Protein inverse docking and its potential use in the computer search of protein targets of a small molecule

Proteins: Structure, Function and Genetics

Volumn 43, Issue 2, 2001, Pages 217-226

  Chen, Y Z ^a   Zhi, D G ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Drug target; Flexible docking; Ligand protein binding; Ligand protein interaction; Molecular recognition; Protein cavity; Rational drug design; Tamoxifen; Target of drug; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LIGAND; M PROTEIN; TAMOXIFEN;

ARTICLE; BINDING AFFINITY; BINDING SITE; COMPUTER ANALYSIS; DRUG DESIGN; DRUG MECHANISM; DRUG PROTEIN BINDING; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN TARGETING;

COMPUTER SIMULATION; DATABASES, FACTUAL; DRUG DESIGN; HUMANS; LIGANDS; MODELS, MOLECULAR; MODELS, THEORETICAL; PROTEIN BINDING; PROTEIN CONFORMATION; RESEARCH DESIGN; TAMOXIFEN; VITAMIN E;

EID: 0035342428     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G     Document Type: Article

References (62)

1. Structure-based strategies for drug design and discovery
2. Structure-based drug design
3. A geometric approach to macromolecule - Ligand recognitions
4. FLOG: A system to select "quasi-flexible" ligands complementary to a receptor of known three dimensional structure
5. A genetic algorithm method for molecular docking molecules
6. Flexible ligand docking using a genetic algorithm
7. Development and validation of a genetic algorithm for flexible docking
8. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming
9. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4
10. The computer program LUDI: A new method for the de novo design of enzyme inhibitors
11. A fast flexible docking method using an incremental construction algorithm
12. Critical evaluation of search algorithms for automated molecular docking and database screening
13. Hammerhead: Fast, fully automated docking of flexible ligands to protein binding sites
14. Hook - A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a molecular binding site
15. QXP: Powerful, rapid computer algorithms for structure-based drug design
16. High resolution fast quantitative docking using fourier domain correlation techniques
17. Flexible docking using Tabu search and an empirical estimate of binding affinity
18. Flexible ligand docking using conformational ensembles
19. Flexible ligand docking: A multistep strategy approach
20. Mechanism of action of adverse drug reactions: An overview
21. New drug development in the United States from 1963 to 1990
22. Strategic choices facing the pharmaceutical industry: A case for innovation
23. 100,000 Protein structures for the biologist
24. Proteomics. An ambitious drug development platform attempts to link gene sequence to expressed phenotype under various physiological states
25. Predicting function: From genes to genomes and back
26. Role of pharmacokinetics and metabolism in drug discovery and development
27. The protein data bank
28. Bridging the protein sequence-structure gap by structure predictions
29. Areas, volumes, packing and protein structure
30. A second generation force field for the simulation of proteins and nucleic acids
31. Simulation of hydrogen bonding in biological systems: Ab initio calculations for NH3-NH3 and NH3-NH4+
32. The role of a minor groove spine of hydration in stabilizing poly(dA).poly(dT) against fluctuational interbase H-bond disruption in the premelting temperature regime
33. Premelting base pair opening probability and drug binding constant of a daunomycin - Poly d(GCAT)-Poly d(ATGC) complex
34. Accommodating protein flexibility in computational drug design
35. Chem-X and CAMBRIDGE. Comparison of computer generated chemical structures with X-ray crystallographic data
36. Steroidal and nonsteroidal oestrogen antagonists in breast cancer: Basic and clinical appraisal
37. Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues
38. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells
39. Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens
40. Leu-enkephalin, tamoxifen and ethanol interactions: Effects on motility and hepatic ethanol metabolizing enzymes
41. The direct inhibition of prostaglandin synthetase of human breast cancer tumor tissue by tamoxifen
42. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen
43. Antagonistic action of estrogens, flutamide, and human growth hormone on androgen-induced changes in the activities of some enzymes of hepatic steroid metabolism in the rat
44. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line
45. The effect of toremifene therapy on serum immunoglobulin levels in breast cancer
46. Autoregulation of corticosteroid receptors. How, when, where, and why?
47. Modulation of calmodulin plasticity in molecular recognition on the basis of X-ray structures
48. Flexible docking allowing induced fit in proteins: Insights from an open to closed conformational isomers
49. In-vitro metabolism of anti-cancer drugs, methods and applications: Paclitaxel, docetaxel, tamoxifen and ifosfamide
50. Binding of alpha-tocopherylquinone, an oxidized form of alpha-tocopherol, to glutathione-S-transferase in the liver cytosol
51. Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol
52. Arachidonic acid metabolites as intratesticular factors controlling androgen production
53. Combined vitamin E deficiency and ethanol pretreatment: Liver glutathione and enzyme changes
54. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: Evidence that astrocytes play an important role in antioxidative processes in the brain
55. Effects of long-term vitamin E deficiency and restoration on rat hepatic peroxisomes
56. Activation of guanyl cyclase during lipid peroxidation of biomembranes
57. Lipoxygenase and other enzymes of arachidonic acid metabolism in the brain of chicks affected by nutritional encephalomalacia
58. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats
59. Changes of some biochemical parameters of the lens in galactose-treated weaned rats with and without vitamin E therapy
60. Effect of supplemental vitamin E on the immune system of calves
61. Antioxidants and gadolinium chloride attenuate hepatic parenchymal and endothelial cell injury induced by low flow ischemia and reperfusion in perfused rat livers
62. High doses of multiple antioxidant vitamins: Essential ingredients in improving the efficacy of standard cancer therapy